COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04733625

Amin Roshdy

Not reported

2021-02-02

Completed

RCT

Randomized

Parallel

Blind label

single-center

Treatment

inclusion criteria: - elderly type ii diabetes adult with age more than 60 years males and females having deficient serum vitamin d levels (less than 25 ng/ml). diabetes patients recruited to the control group were only included in the study if not known to have cholecalciferol supplementation within last 6 weeks. all elderly vitamin d deficient diabetes patients were diagnosed with covid-19 when throat-swab specimens for sars-cov-2 pcr were positive.

- patients with known history of renal stones, diagnosis of hypercalcemia with the past year, baseline serum total calcium more than 10mg/dl, established diagnosis associated with increase the risk of hypercalcemia (e.g. metastatic cancer, sarcoidosis, multiple myeloma, primary hyperparathyroidism), and current vitamin d supplementation moreover, other exclusion criteria included those with known malignancy, with organ transplant, and those with known chronic autoimmune diseases and lastly those on systemic steroid for any cause

2

Kasr El Aini Hospital

18

100

Egypt

No restriction on type of patients

0: No restriction on type of patients

56

Death or need for intubation

None

Not reported

[{"arm_notes": "", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]